Global Small Volume Parenteral Market

Global Small Volume Parenteral Market, By Form (Liquid, Dry), By Dose Type (Single-dose, Multiple-dose), By Packaging Type (Ampoules, Vials, Pre-filled Syringes, Cartridges, Bottles, Others), By Indication Type (Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder/Diarrhea, Diabetes, Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

The small volume parenteral market consists of parenteral drugs and formulations administered in small volumes usually less than 100 milliliter. Small volume parenteral find widespread application in treating conditions such as diabetes, cancer, infections, and congestive heart failures. They aid in delivering medications directly into the bloodstream through routes such as intravenous, intramuscular, subcutaneous, and intradermal delivery. The small volume parenteral formulations market has been witnessing steady growth driven by the growing prevalence of chronic and acute diseases worldwide. Moreover, the rising geriatric population prone to multiple health conditions has boosted the demand for easily administrable drugs in mini doses. However, stringent regulations for manufacturing parenteral drugs and high costs that are associated with drug development may impede the market expansion to some extent.

Market Dynamics:

Global small volume parenteral market is primarily driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, cancer, and respiratory diseases. As per the estimates of World Health Organization (WHO), chronic diseases accounted for over 70% of all deaths worldwide in 2020. Growing geriatric population base which is also susceptible to multiple health issues, has intensified the demand for small volume parenteral formulations to manage complex conditions. Furthermore, advantages such as precise dosing, immediate delivery of medication, and bypassing gastrointestinal absorption have augmented the adoption of small volume parenteral. However, high costs associated with parenteral drug development and stringent regulatory framework for manufacturing injectable drugs continues to restrict the market growth. On the other hand, ongoing advancements in novel drug delivery systems are expected to unleash lucrative opportunities for stakeholders.

Key features of the study:

• This report provides in-depth analysis of the global small volume parenteral market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global small volume parenteral market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Fresenius Kabi AG, Baxter, Sichuan Kelun, BML Parenteral Drugs, ICU Medical, Inc., Pfizer Inc., Becton Dickinson and Company, B. Braun Melsungen AG, WuXi AppTec , Akums Drugs & Pharmaceuticals Ltd., Orion Corporation, Rusoma Laboratories Private Limited, Higgs Healthcare and Syntegon Technology GmbH
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global small volume parenteral market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global small volume parenteral market

Detailed Segmentation:

• Global Small Volume Parenteral Market, By Form
• Liquid
• Dry
• Global Small Volume Parenteral Market, By Dosage Type
• Single-dose
• Multiple-dose
• Global Small Volume Parenteral Market, By Packaging Type
• Ampoules
• Vials
• Pre-filled Syringes
• Cartridges
• Bottles
• Others
• Global Small Volume Parenteral Market, By Indication Type
• Pain Management
• Cancer Care
• Malnourishment
• Gastrointestinal disorder/Diarrhea
• Diabetes
• Others
• Global Small Volume Parenteral Market, By End User
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others
• Global Small Volume Parenteral Market, By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
• Top Companies in the Global Small Volume Parenteral Market:
• Fresenius Kabi AG
• Baxter
• Sichuan Kelun
• BML Parenteral Drugs
• ICU Medical, Inc.
• Pfizer Inc.
• Becton Dickinson and Company
• Braun Melsungen AG
• WuXi AppTec
• Akums Drugs & Pharmaceuticals Ltd.
• Orion Corporation
• Rusoma Laboratories Private Limited
• Higgs Healthcare
• Syntegon Technology GmbH